Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,880 | 181,045 | 36,138 | 25,617 | 54,223 |
| Receivables | 154,726 | 133,758 | 144,293 | 137,231 | 112,055 |
| Inventories | 33,979 | 32,184 | 34,838 | 29,363 | 30,199 |
| TOTAL | $350,241 | $390,537 | $235,645 | $220,699 | $225,552 |
| Non-Current Assets | |||||
| PPE Net | 104,223 | 98,784 | 103,463 | 93,038 | 87,734 |
| Intangibles | 162,877 | 155,120 | 155,592 | 145,840 | 139,220 |
| Other Non-Current Assets | 32,900 | 13,725 | 26,835 | 45,213 | 48,709 |
| TOTAL | $300,000 | $267,629 | $285,890 | $284,091 | $275,663 |
| Total Assets | $650,241 | $658,166 | $521,535 | $504,790 | $501,215 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 147,543 | N/A | N/A | 3,027 | 2,762 |
| Accounts payable and accrued liabilities | 44,710 | 33,009 | 41,588 | 39,861 | 37,460 |
| Accrued Expenses | 28,621 | 24,368 | 28,637 | 25,689 | 24,707 |
| TOTAL | $280,274 | $106,408 | $95,690 | $98,040 | $88,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,864 | N/A | 194,568 | 300,000 | 300,002 |
| Deferred Revenues | 20,181 | 16,528 | 7,932 | 9,130 | 6,853 |
| Other Non-Current Liabilities | 52,803 | 52,705 | 42,650 | 44,504 | 40,457 |
| TOTAL | $77,627 | $270,000 | $237,560 | $344,607 | $340,459 |
| Total Liabilities | $357,901 | $376,408 | $333,250 | $442,647 | $429,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,067 | 44,617 | 45,846 | 45,924 | 46,264 |
| Common Shares | 1,397 | 1,430 | 1,430 | 1,300 | 1,450 |
| Retained earnings | 536,991 | 469,454 | 382,266 | 62,496 | 224,110 |
| Other shareholders' equity | -3,048 | -3,845 | -2,430 | 347 | -1,906 |
| TOTAL | $292,340 | $281,758 | $188,285 | $62,143 | $71,836 |
| Total Liabilities And Equity | $650,241 | $658,166 | $521,535 | $504,790 | $501,215 |